Volume 73, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Subjects in an disease-endemic area in Orissa, India concomitantly infected with filariasis and intestinal helminths had significantly lower intensity of filarial infection in comparison with those who were infected only with filariasis. Administration of albendazole resulted in a significant decrease in the prevalence of filarial antigenemia in subjects concomitantly infected with intestinal helminths, but produced little change in this infection measure in subjects infected only with . These results indicate that intestinal helminths could play a role in the anti-filarial activity of albendazole, most probably by depressing filarial infection intensity in co-infected individuals. Confirmation of these findings in a larger cohort may yield important new insights regarding the role of using albendazole in the ongoing intervention programs for the control of lymphatic filariasis.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Ottesen EA, Ismail MM, Horton J, 1999. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 15 : 382–386.
    [Google Scholar]
  2. Pani SP, Redy GS, Das LK, Vanamail P, Hoti SL, Ramesh J, Das PK, 2002. Tolerability and efficacy of single dose albendazole, diethylcarbamazxine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wucheria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, south India: a hospital-base study. Filaria J 1 : 1–11.
    [Google Scholar]
  3. Dunyo SK, Nkrumah FK, Simonsen PE, 2000. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg 94 : 437–443.
    [Google Scholar]
  4. Sarin R, Dash AP, Dua VK, 2004. Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 799 : 233–238.
    [Google Scholar]
  5. Sahoo PK, Geddam JJB, Satapathy AK, Mohanty MC, Ravindran B, 2000. Bancroftian filariasis: prevalence of antigenaemia and endemic normals in Orissa, India. Trans R Soc Trop Med Hyg 94 : 515–517.
    [Google Scholar]
  6. Zeger SL, Liang KY, 1986. The analysis of discrete and continuous longitudinal data. Biometrics 42 : 121–130.
    [Google Scholar]
  7. Liang KY, Zeger SL, 1986. Longitudinal data analysis using generalized linear models. Biometrika 73 : 13–22.
    [Google Scholar]
  8. Pinheiro JC, Bates DM, 2000. Mixed-Effects Models in S and S-plus. New York: Springer.
  9. Anderson RM, May RM, 1992. Infectious Diseases of Humans. Dynamics and Control. Oxford, United Kingdom: Oxford University Press.
  10. International Filariasis Review Group, (Addiss D, Critchley J, Ejere H, Garner P, Gelband H, Gamble C, 2004. Albendazole for lymphatic filariasis (Cochrane Review). The Cochrane Library, Issue 1. Chichester, United Kingdom: John Wiley & Sons, Ltd.
  11. Collet D, 1991. Modelling Binary Data. London: Chapman & Hall.

Data & Media loading...

  • Received : 28 Jun 2004
  • Accepted : 13 Apr 2005
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error